Medical research is the engine that drives innovation in heart rhythm care. As the field continues to advance and grow in complexity, the Heart Rhythm Society is committed to supporting  you and your colleagues who conduct high-quality groundbreaking research by fostering meaningful collaboration, exchange of insights and ideas, providing career development opportunities, and cultivating connections within the heart rhythm research community.

Asian And Caucasian Female Doctors Talking In Medical Research Center And Using Desktop Computer To Analyze MRI Scans Of Brain. Surgeon And Neuroscientist Discussing Solutions For Treating Alzheimer's
Cropped RN Logo

HRS Research Network

The HRS Research Network is a dedicated platform that aims to serve as a central convener, bringing together the multidisciplinary heart rhythm research community dedicated to improving the lives of patients with heart rhythm disorders through groundbreaking research discoveries.

Learn More

EPRFS Announcement SM

HRS Research Fellowship Scholarships

A post-doctoral research fellowship scholarships in cardiac electrophysiology, aiming to encouraging and supporting the research training of MDs, DOs, and PhDs in cardiac electrophysiology, focused on basic and clinical research.

Learn More

Research Flasks 1200 x 800

Letters of Endorsement for Research Studies Request

HRS offers its members letters of endorsement for basic, translational, and clinical research studies that advance the understanding and treatment of cardiac arrhythmias.

Learn More

capitol 2 1200x800

Research Advocacy

For more than 75 years, sustained federal investment has fueled life-saving discoveries that have transformed the diagnosis, treatment, and prevention of arrhythmias.  Today, the landscape of medical research faces growing uncertainty.  Heart Rhythm Advocates,  the advocacy voice of HRS,  focuses on raising awareness among policymakers and the public about the critical role of medical research & innovation in heart rhythm care.

Learn More

Doctor Working on Laptop

Resources

HRS offers a collection of resources available using the below search engine.

Search & Filter

Date Range

HRS Endorsed

Audience

Topic

Resource Type

Device Type

fallback image

Clinical Trials

The RAFT Trial

In patients with mild to moderate heart failure and a wide QRS complex, the addition of CRT to an ICD reduced rates of death and…

December 16, 2010

fallback image

Clinical Trials

The RACE II Trial

In patients with permanent atrial fibrillation, lenient rate control is as effective as strict rate control and is easier to achieve.

April 15, 2010

fallback image

Clinical Trials

The MADIT-CRT Trial

CRT combined with ICD decreased the risk of heart-failure events in relatively asymptomatic patients with a low ejection fraction and wide QRS complex.

October 1, 2009

fallback image

Clinical Trials

The RE-LY Trial

In patients with AF, dabigatran given at a dose of 110 mg was associated with rates of stroke and systemic embolism that were similar to…

September 17, 2009

fallback image

Clinical Trials

The SCD-HeFT Trial

In patients with heart failure and reduced ejection fraction, implantation of an ICD reduces all-cause mortality.

January 20, 2005

fallback image

Clinical Trials

The COMPANION Trial

In patients with advanced heart failure and a prolonged QRS interval, cardiac-resynchronization therapy decreases the combined risk of death from any cause or first hospitalization…

May 20, 2004

fallback image

Clinical Trials

The DAVID Trial

For patients with standard indications for ICD therapy, no indication for cardiac pacing, and an LVEF of 40% or less, dual-chamber pacing offers no clinical…

December 25, 2002

fallback image

Clinical Trials

The AFFIRM Trial

A comparison of rate control and rhythm control in patients with atrial fibrillation.

December 5, 2002

fallback image

Clinical Trials

The MOST Trial

For sinus-node dysfunction, while dual-chamber pacing does not improve stroke-free survival compared with ventricular pacing, dual-chamber pacing does reduce the risk of atrial fibrillation, signs…

June 13, 2002

fallback image

Clinical Trials

The MADIT II Trial

Implantable cardioverter-defibrillator (ICD) therapy is superior to conventional medical therapy in reducing the risk of death among patients with prior myocardial infarction and reduced ejection…

March 21, 2002